Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
PH-797804
Cat. No.:
OB0225LY-0285
Appearance:
Solid
Purity:
≥97%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Product Overview
Description:
PH-797804 is a selective inhibitor that primarily targets CDK9.
Synonym:
PH797804; 586379-66-0; PH 797804; 3-(3-Bromo-4-((2,4-difluorobenzyl)oxy)-6-methyl-2-oxopyridin-1(2H)-yl)-N,4-dimethylbenzamide; 3-[3-Bromo-4-[(2,4-difluorophenyl)methoxy]-6-methyl-2-oxopyridin-1-yl]-N,4-dimethylbenzamide; 3-(4-(2,4-Difluorobenzyloxy)-3-bromo-6-methyl-2-oxopyridin-1(2H)-yl)-N,4-dimethylbenzamide; 3-Bromo-4-((2,4-difluorobenzyl)oxy)-1-(5-((methylamino)carbonyl)-2-methylphenyl)-6-methylpyridin-2(1H)-one
CAS No.:
586379-66-0
Compound CID:
22049997
Formula:
C22H19BrF2N2O3
Formula Weight:
477.3
Specification
Relative Density:
1.51 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
PH-797804 can be used in cell signaling studies or play an important role in drug target screening.
Library Information
Targets:
Kinases
Receptors:
p38α; p38β
Pathways:
Autophagy; MAPK
Plate Number:
AOCL-4
Plate Location:
f4
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
89 mg/mL; 186.5 mM
Water Max Solubility:
<1 mg/mL (insoluble or slightly soluble)
Ethanol Max Solubility:
7 mg/mL; 14.66 mM
ALogP:
3.801
HBA_Count:
3
HBD_Count:
1
Rotatable Bond:
5
